(Q50939070)

25 March 2018

title

Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis. (English)

1 reference

25 March 2018

primary sclerosing cholangitis

main subject

ascending cholangitis

0 references

1 reference

10

1 reference

25 March 2018

Fridtjof Lund-Johansen

13

1 reference

25 March 2018

Albert Pares

16

1 reference

25 March 2018

Martti Färkkilä

19

1 reference

25 March 2018

Odd Helge Gilja

12

Odd Helge Gilja

1 reference

25 March 2018

Johannes Roksund Hov

2

0 references

William Rosenberg

William Rosenberg

23

0 references

Thor Ueland

21

Thor Ueland

1 reference

25 March 2018

22

Helge Røsjø

1 reference

25 March 2018

5

Ståle Nygård

1 reference

25 March 2018

11

Morten Vatn

1 reference

25 March 2018

Bjørn Moum

20

Bjørn Moum

1 reference

25 March 2018

Kristin Godang

6

Kristin Godang

1 reference

25 March 2018

Tom H Karlsen

25

Tom H Karlsen

1 reference

25 March 2018

Kirsten Muri Boberg

24

Kirsten Muri Boberg

1 reference

25 March 2018

author name string

Mette Vesterhus

1

1 reference

25 March 2018

Anders Holm

3

1 reference

25 March 2018

Erik Schrumpf

4

1 reference

25 March 2018

Ina Marie Andersen

7

1 reference

25 March 2018

Sigrid Naess

8

1 reference

25 March 2018

Douglas Thorburn

9

1 reference

25 March 2018

Trygve Syversveen

14

1 reference

25 March 2018

Knut Brabrand

15

1 reference

25 March 2018

Cyriel Y Ponsioen

17

1 reference

25 March 2018

Massimo Pinzani

18

1 reference

25 March 2018

language of work or name

English

0 references

publication date

28 April 2015

1 reference

25 March 2018

published in

Hepatology

1 reference

25 March 2018

volume

62

1 reference

25 March 2018

issue

1

1 reference

25 March 2018

page(s)

188-197

1 reference

25 March 2018

Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis

cites work

1 reference

Primary sclerosing cholangitis

21 January 2018

1 reference

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

21 January 2018

1 reference

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

21 January 2018

1 reference

Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study.

21 January 2018

1 reference

Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis

21 January 2018

1 reference

Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis

21 January 2018

1 reference

Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis

21 January 2018

1 reference

The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.

21 January 2018

1 reference

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective

21 January 2018

1 reference

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

21 January 2018

1 reference

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay

21 January 2018

1 reference

Diagnosis and management of primary sclerosing cholangitis.

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

21 January 2018

1 reference

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).

21 January 2018

1 reference

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

21 January 2018

1 reference

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

21 January 2018

1 reference

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

21 January 2018

1 reference

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease.

21 January 2018

1 reference

Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C.

21 January 2018

1 reference

Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease

21 January 2018

1 reference

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Accuracy of staging in primary biliary cirrhosis

21 January 2018

1 reference

Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population

21 January 2018

1 reference

Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis

21 January 2018

1 reference

Primary sclerosing cholangitis and cholangiocarcinoma

21 January 2018

1 reference

Clinicopathologic study of cholangiocarcinoma with superficial spread

21 January 2018

1 reference

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

21 January 2018

1 reference

Primary sclerosing cholangitis: refinement and validation of survival models

21 January 2018

1 reference

7 January 2021

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis

1 reference

7 January 2021

Natural history and prognostic variables in primary sclerosing cholangitis

1 reference

7 January 2021

Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis

1 reference

7 January 2021

Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease

1 reference

7 January 2021

ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study

1 reference

7 January 2021

Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver

1 reference

7 January 2021

Correlation between findings on MRCP and gadolinium-enhanced MR of the liver and a survival model for primary sclerosing cholangitis

1 reference

7 January 2021

The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of 'scirrhous-type' and 'nonscirrhous-type' growth

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.27825

1 reference

25 March 2018

1 reference

25 March 2018